• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[动脉粥样硬化的危险因素。差异特征——多种机制?]

[Risk factors of arteriosclerosis. Differential profile--various mechanisms?].

作者信息

Seidel D

机构信息

Institut für Klinische Chemie, Ludwig-Maximilians-Universität München.

出版信息

Z Kardiol. 1993;82 Suppl 5:33-7.

PMID:8154160
Abstract

Up to the present more than 250 factors have been discussed as being risk factors for arteriosclerosis. Yet only a very few pathogenetic mechanisms have actually been proven to be causative in maintaining or complicating the disease. Experimental research in atherosclerosis reflects on a history of approximately 80 years, starting with the remarkable discovery by Windaus in 1912, who for the first time described that in atherosclerotic material 30 times more cholesterol is found as compared to healthy material. Today, due to an enormous quantity of experimental, biochemical, cellular and molecular biological data it is clear that the cholesterol of an atherosclerotic plaque is not being built at the location of deposit but rather derives from circulating plasmalipoproteins, especially from the LDL and IDL particles. Predisposition requires exceeding a threshold concentration of approximately 100 mg/dl cholesterol in plasma and its biological modification. In atherogenesis essentially five cell types are involved: the endothelium, the thrombocytes, the monocyte/macrophage system, the smooth muscle cells of the intima, and the T-lymphocytes. As a consequence of a rather complicated interaction of lipoproteins with these cells changes of the endothelium are initiated which eventually lead to lipid deposition. From early clusters, the so-called fatty streaks, and under unfavorable circumstances and unlimited growth atherosclerotic plaques may develop with the inherent danger of rupture and thrombotic occlusion. The vulnerability respectively the resistance of the arterial wall towards hypercholesterolemia is influenced by other so-called primary risk factors such as hypertension, cigarette smoking, diabetes mellitus, and hyperfibrinogenemia.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

到目前为止,已有超过250种因素被讨论为动脉粥样硬化的危险因素。然而,实际上只有极少数致病机制被证明在维持疾病或使疾病复杂化方面具有因果关系。动脉粥样硬化的实验研究反映了大约80年的历史,始于1912年温道斯的重大发现,他首次描述了在动脉粥样硬化物质中发现的胆固醇比健康物质多30倍。如今,由于大量的实验、生化、细胞和分子生物学数据,很明显动脉粥样硬化斑块中的胆固醇并非在沉积部位形成,而是来源于循环血浆脂蛋白,尤其是低密度脂蛋白和中间密度脂蛋白颗粒。易感性要求血浆中胆固醇浓度超过约100mg/dl的阈值并对其进行生物学修饰。在动脉粥样硬化形成过程中,主要涉及五种细胞类型:内皮细胞、血小板、单核细胞/巨噬细胞系统、内膜平滑肌细胞和T淋巴细胞。由于脂蛋白与这些细胞的相当复杂的相互作用,引发了内皮细胞的变化,最终导致脂质沉积。从早期的簇状结构,即所谓的脂肪条纹开始,在不利的情况下且不受限制地生长,可能会形成动脉粥样硬化斑块,并存在破裂和血栓闭塞的内在危险。动脉壁对高胆固醇血症的易损性或抵抗力受到其他所谓的主要危险因素的影响,如高血压、吸烟、糖尿病和高纤维蛋白原血症。(摘要截选至250字)

相似文献

1
[Risk factors of arteriosclerosis. Differential profile--various mechanisms?].[动脉粥样硬化的危险因素。差异特征——多种机制?]
Z Kardiol. 1993;82 Suppl 5:33-7.
2
[Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].[1型糖尿病合并高胆固醇血症患儿动脉粥样硬化相关危险因素评估]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):25-30.
3
[New pieces in the puzzle of atherogenesis].
Rev Med Chil. 1999 Aug;127(8):996-1003.
4
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.口服避孕甾体激素对动脉血栓形成生化标志物的药效学作用。非糖尿病女性和胰岛素依赖型糖尿病女性的研究。
Dan Med Bull. 2002 Feb;49(1):43-60.
5
Atherosclerosis: cellular aspects and potential interventions.动脉粥样硬化:细胞层面及潜在干预措施
Cerebrovasc Brain Metab Rev. 1991 Summer;3(2):114-33.
6
[New information on the pathophysiology of atherosclerosis].[动脉粥样硬化病理生理学的新信息]
Lijec Vjesn. 2001 Jan-Feb;123(1-2):26-31.
7
[Risk factors for arteriosclerosis].[动脉粥样硬化的危险因素]
Praxis (Bern 1994). 2001 Jan 25;90(4):91-5.
8
Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.致动脉粥样硬化的致密低密度脂蛋白。病理生理学与新治疗方法。
Eur Heart J. 1998 Feb;19 Suppl A:A24-30.
9
[Pathophysiology of atherosclerosis. II. Etiopathogenic mechanisms and risk factors].[动脉粥样硬化的病理生理学。II. 病因发病机制和危险因素]
Lijec Vjesn. 1990 May-Jun;112(5-6):175-82.
10
[The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium].[低密度脂蛋白在动脉粥样硬化起源和进展中的作用:动脉粥样硬化病变起源和发展的病理生物学概念及内皮的作用]
G Ital Cardiol. 1998 Feb;28(2):158-67.